Study Results: Biologica Technologies’ ProteiOS in Foot and Ankle Arthrodesis

Biologica Technologies, developers of ProteiOS® growth factor and OsseoGEN® cellular bone matrix, announced early topline results from a retrospective, multicenter study evaluating the safety and effectiveness of ProteiOS in foot and ankle fusion. Thus far, study results show fusion rates that are higher than or comparable to those in other...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us